Table 2.

Treatments before Axitinib

	1st line (n = 22)		2nd line (n = 22)		3rd line (n = 10)		4th line (n = 6)		5th line (n = 3)
Agent(s)	n	%	n	%	n	%	n	%	n	%
Sunitinib	14	63.6	0	0	1	10	0	0	0	0
Pazopanib	3	13.6	3	13.6	1	10	4	66.6	1	33.3
Sunitinib- Everolimus (Sequential)	4	18.2	4	18.2	0	0	0	0	0	0
Bevacizumab	1	4.5	0	0	1	10	0	0	0	0
Temsirolimus- Bevacizumab (Concurrent)	0	0	2	9	0	0	0	0	0	0
Nivolumab	0	0	1	4.5	1	10	0	0	0	0
Sorafenib	0	0	1	4.5	3	30	0	0	0	0
Dovitinib	0	0	0	0	1	10	0	0	0	0
Everolimus	0	0	11	50	2	20	2	33.3	0	0
Temsirolimus	0	0	0	0	0	0	0	0	2	66.6
Total	22	100	22	100	10	100	6	100	3	100